AU2003299962A1 - Interferon drug therapy for the treatment of viral diseases and liver fibrosis - Google Patents
Interferon drug therapy for the treatment of viral diseases and liver fibrosisInfo
- Publication number
- AU2003299962A1 AU2003299962A1 AU2003299962A AU2003299962A AU2003299962A1 AU 2003299962 A1 AU2003299962 A1 AU 2003299962A1 AU 2003299962 A AU2003299962 A AU 2003299962A AU 2003299962 A AU2003299962 A AU 2003299962A AU 2003299962 A1 AU2003299962 A1 AU 2003299962A1
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- drug therapy
- liver fibrosis
- viral diseases
- interferon drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003225670 | 2003-02-28 | ||
PCT/US2003/006687 WO2004078194A1 (en) | 2003-02-28 | 2003-02-28 | Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
AU2003287145 | 2003-10-14 | ||
PCT/US2003/032539 WO2004078193A1 (en) | 2003-02-28 | 2003-10-14 | Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
PCT/US2003/041369 WO2004078207A1 (en) | 2003-02-28 | 2003-12-23 | Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003299962A1 true AU2003299962A1 (en) | 2004-09-28 |
Family
ID=32965092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003299962A Abandoned AU2003299962A1 (en) | 2003-02-28 | 2003-12-23 | Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1596883A1 (en) |
AU (1) | AU2003299962A1 (en) |
WO (1) | WO2004078207A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8034764B2 (en) * | 2003-10-21 | 2011-10-11 | Medtronic Minimed, Inc. | Modulation of SOCS expression in therapeutic regimens |
CU23432B6 (en) * | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | STABILIZED FORMULATIONS CONTAINING GAMMA AND ALFA INTERFERONS IN POTENTIAL PROPORTIONS |
CA2665438C (en) * | 2006-10-04 | 2014-12-02 | Tibotec Pharmaceuticals Ltd. | Carboxamide 4-[(4-pyridyl)amino]pyrimidines useful as hcv inhibitors |
ES2439954T3 (en) * | 2007-02-23 | 2014-01-27 | Her Majesty The Queen, In Right Of Canada, As Represented By The Minister Of National Defence | Recombinant viral vectors for prevention and protection against alphavirus infection |
MX2007009796A (en) | 2007-08-14 | 2009-02-25 | Cell Therapy And Technology S | Gel containing pirfenidone. |
MX346763B (en) | 2012-03-28 | 2017-03-31 | Cell Therapy And Tech S A De C V | Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne. |
CN103387601B (en) * | 2012-05-11 | 2017-01-11 | 南开大学 | Anti-dengue virus (DENV) heterocyclic peptide compounds and preparing methods and uses thereof |
CN103421083A (en) * | 2012-05-16 | 2013-12-04 | 南开大学 | Anti-dengue virus heterocycle peptide compounds having 1,2,3-triazole structure, preparation method and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936694B1 (en) * | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
JP3838034B2 (en) * | 1997-10-13 | 2006-10-25 | 大塚製薬株式会社 | Hepatitis C therapeutic effect improving agent and its application |
US6103531A (en) * | 1998-02-13 | 2000-08-15 | Ohio State Research Foundation | Methods of disrupting interferon signal transduction pathways |
-
2003
- 2003-12-23 AU AU2003299962A patent/AU2003299962A1/en not_active Abandoned
- 2003-12-23 WO PCT/US2003/041369 patent/WO2004078207A1/en not_active Application Discontinuation
- 2003-12-23 EP EP03800228A patent/EP1596883A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1596883A1 (en) | 2005-11-23 |
WO2004078207A1 (en) | 2004-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200410229B (en) | Administration of therapeutic viruses | |
AU2003220317A1 (en) | Methods and drug delivery systems for the treatment of orofacial diseases | |
IL157364A0 (en) | Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1 | |
IL169338A0 (en) | Therapeutic formulations for the treatment of beta-amyloid related diseases | |
HK1164133A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
AU2002329990A1 (en) | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith | |
AU2003261251A1 (en) | Methods of delivering therapeutic agents | |
AU2003225281A1 (en) | Materials and methods for prevention and treatment of rna viral diseases | |
AU2002322719A1 (en) | Delivery of therapeutic capable agents | |
WO2003072035A8 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004041170A9 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2003259381A1 (en) | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases | |
WO2004024097A9 (en) | Compositions and methods for the treatment of immune related diseases | |
EP1572709A3 (en) | Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases | |
ZA200707934B (en) | Thereapeutic formulations for the treatment of beta-amyloid related diseases | |
HK1091727A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
AU2003287145A1 (en) | Interferon drug therapy for the treatment of viral diseases and liver fibrosis | |
HK1095036A1 (en) | Virus therapeutic drug | |
AU3009801A (en) | Combinations of medicaments for treating viral diseases | |
AU5618501A (en) | Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis | |
AU2003299962A1 (en) | Interferon drug therapy for the treatment of viral diseases and liver fibrosis | |
AU2003273983A1 (en) | Viral vectors and the use of the same for gene therapy | |
AU2002359618A1 (en) | Medicinal compositions and therapeutic methods | |
AU2002325169A1 (en) | Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases | |
AU2003256280A1 (en) | Methods of delivering gene therapy agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |